Immuron IMRN
NASDAQ IMRN
$1.24 +0.02 (+1.64%)
At close: Sep 21, 2026 · 4:00 PM EDT

Immuron (IMRN) Profit After Tax (2016 - 2025)

Immuron (IMRN) posted Profit After Tax of -$3.3 million for Q2 2025, down 7129.21% on a QoQ basis from -$46208.3 in Q3 2024, and up 26.93% year-over-year from -$2.6 million in Q2 2024.

Analysis

Immuron (IMRN) Profit After Tax (2016 - 2025) Analysis & Trends

Immuron has reported Profit After Tax for 10 years, with the latest figure at -$3.3 million in Q2 2025.

  • On a quarterly basis, Profit After Tax rose 26.93% year-over-year to -$3.3 million in Q2 2025; TTM through Jun 2025 was -$10.4 million, a 12.91% decrease from a year earlier, with the FY2026 full-year figure at $16311.0, up 120210.46% from the prior year.
  • Profit After Tax was -$3.3 million for Q2 2025 at Immuron, down from -$46208.3 in the prior quarter.
  • The five-year high for Profit After Tax was -$13260.2 in Q4 2021, with the low at -$6.5 million in Q2 2021.
  • Average Profit After Tax over 5 years is -$2.4 million, with a median of -$2.2 million recorded in 2022.
  • The sharpest annual moves came in 2021 and 2022: Profit After Tax jumped 68.39% in 2021, then slumped 14819.74% in 2022.
  • Over 5 years, Profit After Tax stood at -$13260.2 in 2021, then plunged by 14819.74% to -$2.0 million in 2022, then slipped by 24.6% to -$2.5 million in 2023, then soared by 98.13% to -$46208.3 in 2024, then sank by 7129.21% to -$3.3 million in 2025.
  • The last three Profit After Tax figures came in at -$3.3 million (Q2 2025), -$46208.3 (Q3 2024), and -$4.6 million (Q2 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn 2.38 Bn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn -10.50 Bn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn 1.10 Bn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn 1.30 Bn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn -782.00 Mn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn 472.00 Mn
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn 164.49 Mn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn 97.50 Mn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn -290.61 Mn
10 Immuron 7.14 Mn -1.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -3.34 Mn
Sep 9, 2024 -46,208.27
Jun 30, 2024 -4.57 Mn
Dec 31, 2023 -2.46 Mn
Jun 30, 2023 -216,776.03
Dec 31, 2022 -1.98 Mn
Dec 31, 2021 -13,260.17
Jun 30, 2021 -6.46 Mn
Dec 31, 2020 -41,946.68
Jun 30, 2020 -1.92 Mn
Dec 31, 2019 -15,212.27
Dec 31, 2018 -1.58 Mn
Dec 31, 2017 -1.45 Mn
Dec 31, 2016 -2.57 Mn
Jun 30, 2016 -3.28 Mn
API Access

Immuron Profit After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=IMRN&period=max&api_key=YOUR_API_KEY